Literature DB >> 521486

Cultures for Clostridium difficile in stools containing a cytotoxin neutralized by Clostridium sordellii antitoxin.

S H Willey, J G Bartlett.   

Abstract

Stools from patients with antibiotic-associated diarrhea or colitis were cultured to detect the presence of Clostridium difficile. All specimens contained a cytotoxin which was neutralized by Clostridium sordellii antitoxin. Initial testing employed several methods with comparative merits in recovering this organism. These included the use of nonselective media, antibiotic-incorporated media, alcohol shock, and paracresol-containing broth. Optimal results were achieved with primary plating of serial dilutions onto a selective agar containing cycloserine and cefoxitin. This technique was then employed in a large number of specimens. The overall results showed that C. difficile was recovered in specimens from 71 of 73 patients. All isolates of C. difficile produced a cytotoxin which was neutralized by C. sordellii antitoxin in vitro. These results verify the utility of this medium and support the concept that C. difficile accounts for the cytotoxin found in stools in nearly all cases.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 521486      PMCID: PMC273287          DOI: 10.1128/jcm.10.6.880-884.1979

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  15 in total

1.  Partial purification and characterization of a cytotoxin from Clostridium difficile.

Authors:  N S Taylor; J G Bartlett
Journal:  Rev Infect Dis       Date:  1979 Mar-Apr

2.  Identification of Clostridium difficile as a cause of pseudomembranous colitis.

Authors:  R H George; J M Symonds; F Dimock; J D Brown; Y Arabi; N Shinagawa; M R Keighley; J Alexander-Williams; D W Burdon
Journal:  Br Med J       Date:  1978-03-18

3.  Antibiotic-associated pseudomembranous colitis due to toxin-producing clostridia.

Authors:  J G Bartlett; T W Chang; M Gurwith; S L Gorbach; A B Onderdonk
Journal:  N Engl J Med       Date:  1978-03-09       Impact factor: 91.245

4.  Neutralization of Clostridium difficile toxin by Clostridium sordellii antitoxins.

Authors:  T W Chang; S L Gorbach; J B Bartlett
Journal:  Infect Immun       Date:  1978-11       Impact factor: 3.441

5.  Randomised controlled trial of vancomycin for pseudomembranous colitis and postoperative diarrhoea.

Authors:  M R Keighley; D W Burdon; Y Arabi; J A Williams; H Thompson; D Youngs; M Johnson; S Bentley; R H George; G A Mogg
Journal:  Br Med J       Date:  1978-12-16

6.  Selective and differential medium for isolation of Clostridium difficile.

Authors:  W L George; V L Sutter; D Citron; S M Finegold
Journal:  J Clin Microbiol       Date:  1979-02       Impact factor: 5.948

Review 7.  Antibiotic-associated pseudomembranous colitis.

Authors:  J G Bartlett
Journal:  Rev Infect Dis       Date:  1979 May-Jun

8.  Role of Clostridium difficile in antibiotic-associated pseudomembranous colitis.

Authors:  J G Bartlett; N Moon; T W Chang; N Taylor; A B Onderdonk
Journal:  Gastroenterology       Date:  1978-11       Impact factor: 22.682

9.  Pseudomembranous colitis: Presence of clostridial toxin.

Authors:  H E Larson; A B Price
Journal:  Lancet       Date:  1977 Dec 24-31       Impact factor: 79.321

10.  Clostridium difficile and the aetiology of pseudomembranous colitis.

Authors:  H E Larson; A B Price; P Honour; S P Borriello
Journal:  Lancet       Date:  1978-05-20       Impact factor: 79.321

View more
  35 in total

1.  Rapid and sensitive loop-mediated isothermal amplification test for Clostridium difficile detection challenges cytotoxin B cell test and culture as gold standard.

Authors:  Torbjörn Norén; Ingegärd Alriksson; Josefin Andersson; Thomas Akerlund; Magnus Unemo
Journal:  J Clin Microbiol       Date:  2010-11-24       Impact factor: 5.948

Review 2.  Clostridium difficile toxins: mechanism of action and role in disease.

Authors:  Daniel E Voth; Jimmy D Ballard
Journal:  Clin Microbiol Rev       Date:  2005-04       Impact factor: 26.132

3.  Clostridium difficile in neonates: serogrouping and epidemiology.

Authors:  M Delmée; G Verellen; V Avesani; G Francois
Journal:  Eur J Pediatr       Date:  1988-01       Impact factor: 3.183

4.  Correlation of immunoblot type, enterotoxin production, and cytotoxin production with clinical manifestations of Clostridium difficile infection in a cohort of hospitalized patients.

Authors:  L V McFarland; G W Elmer; W E Stamm; M E Mulligan
Journal:  Infect Immun       Date:  1991-07       Impact factor: 3.441

5.  Rectal swab cultures for Clostridium difficile surveillance studies.

Authors:  L V McFarland; M B Coyle; W H Kremer; W E Stamm
Journal:  J Clin Microbiol       Date:  1987-11       Impact factor: 5.948

6.  Gas chromatographic identification of Clostridium difficile and detection of cytotoxin from a modified selective medium.

Authors:  P N Levett; K D Phillips
Journal:  J Clin Pathol       Date:  1985-01       Impact factor: 3.411

7.  Effect of antibiotic concentration in a selective medium on the isolation of Clostridium difficile from faecal specimens.

Authors:  P N Levett
Journal:  J Clin Pathol       Date:  1985-02       Impact factor: 3.411

8.  Commercial latex agglutination test for detection of Clostridium difficile-associated diarrhea.

Authors:  M T Kelly; S G Champagne; C H Sherlock; M A Noble; H J Freeman; J A Smith
Journal:  J Clin Microbiol       Date:  1987-07       Impact factor: 5.948

9.  Clostridium difficile and cytotoxin in routine faecal specimens.

Authors:  J Q Nash; B Chattopadhyay; J Honeycombe; S Tabaqchali
Journal:  J Clin Pathol       Date:  1982-05       Impact factor: 3.411

10.  Isolation of Clostridium difficile from hospitalized patients without antibiotic-associated diarrhea or colitis.

Authors:  N M Varki; T I Aquino
Journal:  J Clin Microbiol       Date:  1982-10       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.